<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200708048064N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-11-23</date_registration>
      <primary_sponsor>Karaj University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Dimethicon On Prevention Of Ileus In Patients Suffering From Pelvic and Femoral Fractures A Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Dimethicon On Prevention Of Ileus In Patients Suffering From Pelvic and Femoral Fractures A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-11-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>110</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50357</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Block Randomization will be used.
Each block will contain 4 individuals. The sequence of patients in each block is random. The number of subjects is equal and two are from the intervention group and two are from the control group.               
Stratification of Randomization will not be used.</study_design>
      <phase>3</phase>
      <hc_freetext>Ileus In Hip and femoral fracture Patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Dimethicone 40 mg Pills will be given to the Intervention group three times a day and it will be consumed from the point of admission in hospital.  So far, no study has been conducted to investigate the effect of dimethicone to prevent ileus following pelvic and femoral fractures. The closest study was to investigate the effect of simethicone on ileus after colorectal surgery.(1) In some cases, acupuncture and simo decoction, alvimopan and chewing gum, in studies have been useful in the treatment of ileus.(2 , 3 , 4) Despite several studies on the factors affecting the incidence of ileus and the study of different treatments, a suitable preventive method has not yet been suggested  to prevent this complication, which indicates the necessity of further and wider studies in this case, so due to the high prevalence of ileus in patients of Madani hospital, it was decided to investigate a method to prevent this disease.                                                                            References:                                                                                                                          (1Jeremy E.Springer ShirazElkheir CaglaEskicioglu Aristithes  G.Doumouras StephenKelly IlunYangaShawnForbes. The effect of simethicone on postoperative ileus in patients undergoing colorectal surgery(SPOT), a randomized controlled trial. International Journal of Surgery Volume 56, August 2018, Pages141-147)                                                                                (2 Wolff BG, Michelassi F, Gerkin TM, Techner L, Gabriel K, Du W, et al. Alvimopan, a Novel, Peripherally .1Acting μ Opioid Antagonist: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, PhaseIII Trial of Major Abdominal Surgery and Postoperative Ileus. Annals of surgery. 2004;240(4):728-35.)                                                                                                          (3 Yang Y, Zuo HQ, Li Z, Qin YZ, Mo XW, Huang MW, et al. Comparison of efficacy of simo decoction and acupuncture or chewing gum alone on postoperative ileus in colorectal cancer resection: a randomized trial.Scientific reports. 2017;7:37826. )                                                                                       (4 van den Heijkant TC, Costes LM, van der Lee DG, Aerts B, Osinga-de Jong M, Rutten HR, et al.Randomized clinical trial of the effect of gum chewing on postoperative ileus and inflammation in colorectal surgery. The British journal of surgery. 2015;102(3):202-11. ). Intervention 2: Control group:The Control Group will be Treated with Routine Care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Haleh paak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid madani Square,  Jahanshar , Karaj</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3155718631</zip>
        <telephone>+98 26 3250 8967</telephone>
        <email>halehpak80.md@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Haleh paak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid madani Square,  Jahanshar , Karaj</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3155718631</zip>
        <telephone>+98 26 3250 8967</telephone>
        <email>halehpak80.md@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: All patients with different types of pelvic and femoral fractures who were admitted to Madani Hospital for at least 3 days and treated during the study.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Exclusion criteria: Patients will be excluded if they have symptoms of ileus or take prokinetic drugs before surgery.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K56.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Paralytic ileus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Dimethicone 40 mg Pills will be given to the Intervention group three times a day and it will be consumed from the point of admission in hospital.  So far, no study has been conducted to investigate the effect of dimethicone to prevent ileus following pelvic and femoral fractures. The closest study was to investigate the effect of simethicone on ileus after colorectal surgery.(1) In some cases, acupuncture and simo decoction, alvimopan and chewing gum, in studies have been useful in the treatment of ileus.(2 , 3 , 4) Despite several studies on the factors affecting the incidence of ileus and the study of different treatments, a suitable preventive method has not yet been suggested  to prevent this complication, which indicates the necessity of further and wider studies in this case, so due to the high prevalence of ileus in patients of Madani hospital, it was decided to investigate a method to prevent this disease.                                                                            References:                                                                                                                          (1Jeremy E.Springer ShirazElkheir CaglaEskicioglu Aristithes  G.Doumouras StephenKelly IlunYangaShawnForbes. The effect of simethicone on postoperative ileus in patients undergoing colorectal surgery(SPOT), a randomized controlled trial. International Journal of Surgery Volume 56, August 2018, Pages141-147)                                                                                (2 Wolff BG, Michelassi F, Gerkin TM, Techner L, Gabriel K, Du W, et al. Alvimopan, a Novel, Peripherally .1Acting μ Opioid Antagonist: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, PhaseIII Trial of Major Abdominal Surgery and Postoperative Ileus. Annals of surgery. 2004;240(4):728-35.)                                                                                                          (3 Yang Y, Zuo HQ, Li Z, Qin YZ, Mo XW, Huang MW, et al. Comparison of efficacy of simo decoction and acupuncture or chewing gum alone on postoperative ileus in colorectal cancer resection: a randomized trial.Scientific reports. 2017;7:37826. )                                                                                       (4 van den Heijkant TC, Costes LM, van der Lee DG, Aerts B, Osinga-de Jong M, Rutten HR, et al.Randomized clinical trial of the effect of gum chewing on postoperative ileus and inflammation in colorectal surgery. The British journal of surgery. 2015;102(3):202-11. )</i_keyword>
      <i_keyword>Control group:The Control Group will be Treated with Routine Care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Determining Incidence rate of Ileus in patients receiving dimethicone. Timepoint: From the onset of admission in ward. Method of measurement: Patient History - Clinical Examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Comparison of gas passage time between intervention and control groups. Timepoint: From hospitalization until gas passage during hospitalization. Method of measurement: Patient history.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Karaj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-10</approval_date>
        <contact_name>Ethics comittee of Alborz University of Medical Sciences</contact_name>
        <contact_address>Research and Technology Committee - Saffari Ave , 45 meter Golshahr Street , Karaj کرج Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
